Visby Medical, Inc.
San Jose, CA · Founded 2012 · CIK 0001657186 · Medtech · Private
PCR-based rapid disposable point-of-care diagnostic test that detects gonorrhea and determines antibiotic susceptibility from a single sample
clickdiagnostics.com →- Grants
- $2.5M
- 4 awards
- Sector median: 1
- Raised
- $235M
- 4 Form D · Mar 2022
- 55 months since last filing
- Contracts
- $52M
- 4 awards · Health and Human S, Defense
- #17 of 4531 in medtech
- Patents
- 25
- 13 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $16,003,748 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of low cost, disposable, point-of-care molecular diagnostic device for sexually transmitted infections | $1,448,379 | |
| Private capital raised | Form D · SEC | $9,520,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of low cost, disposable, point-of-care molecular diagnostic device for sexually transmitted infections | $467,645 | |
| Federal grant | Department of Health and Human Services · Phase I · Development, Preclinical and Preanalytical Evaluation of a Rapid Point-of-Care NAAT Device to determine Ciprofloxacin Sensitivity of Gonococci in Urogenital Samples | $300,000 | |
| Private capital raised | Form D · SEC | $100,807,816 | |
| Federal contract | Department of Health and Human Services · Phs 2019-1, SBIR Topic 075 | $140,000 | |
| Federal contract | Department of Defense · Handheld Device/cartridge COVID-19 | $920,600 | |
| Federal contract | Department of Health and Human Services · Radx Tech - Visby Medical Inc. For Single-use (disposable), Fully-integrated, Rapid, Automated Rt-pcr In Vitro Diagnostic Test | $9,498,805 | |
| Federal contract | Department of Health and Human Services · A Rapid, Accurate, Poc Disposable Influenza And SARS-COV-2 Molecular Diagnostic | $41,169,014 | |
| Private capital raised | Form D · SEC | $108,621,185 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 14 | BANYAN BIOMARKERS, INC. | $62M | $14M |
| 15 | FIREFLY NEUROSCIENCE, INC. | $56M | $19M |
| 16 | RIVANNA MEDICAL, INC. | $52M | $370K |
| 17 | Visby Medical, Inc. | $52M | $235M |
| 18 | Tempus AI | $51M | — |
| 19 | SIMETRI, INC. | $50M | — |
| 20 | ROTECH HEALTHCARE INC | $47M | $6.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jerome BeharDirector
- JEROME BEHARDirector
- Terri BresenhamDirector
- Adam de la ZerdaDirector · Executive Officer
- ADAM DE LA ZERDADirector · Executive Officer · Promoter
- David EngmanDirector
- Mark IbisonExecutive Officer
- John KuoExecutive Officer
- Gregory LoneyExecutive Officer
- Shlomo MelmedDirector
- Scott MendelDirector
- Eric MoessingerDirector
- Thomas PrescottDirector
- STEVEN ROSSTONDirector
- Amit ShahDirector
- AJIT SINGHDirector · Executive Officer
Patents
- Molecular Diagnostic Devicegranted
- Molecular Diagnostic Devices With Digital Detection Capability And Wireless Connectivityapplication
- Devices And Methods For Molecular Diagnostic Testingapplication
- Molecular Diagnostic Devicegranted
- Molecular Diagnostic Devices And Methods For Retaining And Mixing Reagentsapplication
- Molecular Diagnostic Devices With Digital Detection Capability And Wireless Connectivitygranted
- Portable Molecular Diagnostic Device And Methods For The Detection Of Target Virusesapplication
- Devices And Methods For Antibiotic Susceptibility Testinggranted
- Molecular Diagnostic Devices And Methodsapplication
- Molecular Diagnostic Devicegranted
- Printed Circuit Board Heater For An Amplification Modulegranted
- Molecular Diagnostic Devicegranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.